Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
HARBIN GLORIA PHARMACEUTICALS Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
HARBIN GLORIA PHARMACEUTICALS has a total shareholder equity of CN¥1.9B and total debt of CN¥115.1M, which brings its debt-to-equity ratio to 5.9%. Its total assets and total liabilities are CN¥2.8B and CN¥899.1M respectively. HARBIN GLORIA PHARMACEUTICALS's EBIT is CN¥157.1M making its interest coverage ratio 55.7. It has cash and short-term investments of CN¥433.9M.
Anahtar bilgiler
5.9%
Borç/özkaynak oranı
CN¥115.07m
Borç
| Faiz karşılama oranı | 55.7x |
| Nakit | CN¥433.92m |
| Eşitlik | CN¥1.94b |
| Toplam yükümlülükler | CN¥899.14m |
| Toplam varlıklar | CN¥2.84b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002437's short term assets (CN¥874.1M) exceed its short term liabilities (CN¥837.7M).
Uzun Vadeli Yükümlülükler: 002437's short term assets (CN¥874.1M) exceed its long term liabilities (CN¥61.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002437 has more cash than its total debt.
Borcun Azaltılması: 002437's debt to equity ratio has reduced from 64.7% to 5.9% over the past 5 years.
Borç Kapsamı: 002437's debt is well covered by operating cash flow (237.8%).
Faiz Kapsamı: 002437's interest payments on its debt are well covered by EBIT (55.7x coverage).